1IZB

ROLE OF B13 GLU IN INSULIN ASSEMBLY: THE HEXAMER STRUCTURE OF RECOMBINANT MUTANT (B13 GLU-> GLN) INSULIN


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2 Å

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Role of B13 Glu in insulin assembly. The hexamer structure of recombinant mutant (B13 Glu-->Gln) insulin.

Bentley, G.A.Brange, J.Derewenda, Z.Dodson, E.J.Dodson, G.G.Markussen, J.Wilkinson, A.J.Wollmer, A.Xiao, B.

(1992) J.Mol.Biol. 228: 1163-1176

  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • The assembly of the insulin hexamer brings the six B13 glutamate side-chains at the centre into close proximity. Their mutual repulsion is unfavourable and zinc co-ordination to B10 histidine is necessary to stabilize the well known zinc-containing h ...

    The assembly of the insulin hexamer brings the six B13 glutamate side-chains at the centre into close proximity. Their mutual repulsion is unfavourable and zinc co-ordination to B10 histidine is necessary to stabilize the well known zinc-containing hexamers. Since B13 is always a carboxylic acid in all known sequences of hexamer forming insulins, it is likely to be important in the hormone's biology. The mutation of B13 Glu-->Gln leads to a stable zinc-free hexamer with somewhat reduced potency. The structures of the zinc-free B13 Gln hexamer and the 2Zn B13 insulin hexamer have been determined by X-ray analysis and refined with 2.5 A and 2.0 A diffraction data, respectively. Comparisons show that in 2Zn B13 Gln insulin, the hexamer structure (T6) is very like that of the native hormone. On the other hand, the zinc-free hexamer assumes a quaternary structure (T3/R3) seen in the native 4Zn insulin hexamer, and normally associated only with high chloride ion concentrations in the medium. The crystal structures show the B13 Gln side-chains only contact water in contrast to the B13 glutamate in 2Zn insulin. The solvation of the B13 Gln may be associated with this residue favouring helix at B1 to B8. The low potency of the B13 Gln insulin also suggests the residue influences the hormone's conformation.


    Related Citations: 
    • The Structure of 2Zn Pig Insulin Crystals at 1.5 Angstroms Resolution
      Baker, E.N.,Blundell, T.L.,Cutfield, J.F.,Cutfield, S.M.,Dodson, E.J.,Dodson, G.G.,Crowfoot Hodgkin, D.M.,Hubbard, R.E.,Isaacs, N.W.,Reynolds, C.D.,Sakabe, K.,Sakabe, N.,Vijayan, N.M.
      (1988) Philos.Trans.R.Soc.London,Ser.B 319: 369


    Organizational Affiliation

    Institut Pasteur, Paris, France.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
INSULIN
A, C
21Sus scrofaMutation(s): 0 
Gene Names: INS
Find proteins for P01315 (Sus scrofa)
Go to Gene View: INS
Go to UniProtKB:  P01315
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
INSULIN
B, D
30Sus scrofaMutation(s): 1 
Gene Names: INS
Find proteins for P01315 (Sus scrofa)
Go to Gene View: INS
Go to UniProtKB:  P01315
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
ZN
Query on ZN

Download SDF File 
Download CCD File 
B, D
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2 Å
  • Space Group: H 3
Unit Cell:
Length (Å)Angle (°)
a = 82.850α = 90.00
b = 82.850β = 90.00
c = 34.100γ = 120.00
Software Package:
Software NamePurpose
PROLSQrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 1992-10-16 
  • Released Date: 1993-10-31 
  • Deposition Author(s): Xiao, B., Dodson, G.G.

Revision History 

  • Version 1.0: 1993-10-31
    Type: Initial release
  • Version 1.1: 2008-03-03
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance